CDK7 and non-small cell lung carcinoma: Cyclin-dependent kinase 7 (CDK7)/MYC/PD-L1 signaling cascade have been demonstrated to enhance PD-L1 expression, and the CDK7 inhibitor, THZ1, downregulated PD-L1 expression by suppressing MYC activity in NSCLC [91].